192 related articles for article (PubMed ID: 34375672)
1. Cigarette smoking and nicotine exposure contributes for aberrant insulin signaling and cardiometabolic disorders.
Rehman K; Haider K; Akash MSH
Eur J Pharmacol; 2021 Oct; 909():174410. PubMed ID: 34375672
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
Kathuria S; Mahadevan N; Balakumar P
Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
[TBL] [Abstract][Full Text] [Related]
3. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.
Chen L; Xu WM; Zhang D
Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome.
Hyderali BN; Mala K
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():15-22. PubMed ID: 26066290
[TBL] [Abstract][Full Text] [Related]
5. Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products.
Klein J; Diaba-Nuhoho P; Giebe S; Brunssen C; Morawietz H
Pflugers Arch; 2023 Jul; 475(7):835-844. PubMed ID: 37285061
[TBL] [Abstract][Full Text] [Related]
6. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms.
Rahman MM; Laher I
Curr Vasc Pharmacol; 2007 Oct; 5(4):276-92. PubMed ID: 17979794
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking and endothelial damage.
Sela BA
Isr Med Assoc J; 2002 Nov; 4(11):1077-9. PubMed ID: 12489510
[No Abstract] [Full Text] [Related]
10. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study.
Fatima Q; Amin S; Kawa IA; Jeelani H; Manzoor S; Rizvi SM; Rashid F
Diabetes Metab Syndr; 2019; 13(3):1957-1961. PubMed ID: 31235121
[TBL] [Abstract][Full Text] [Related]
11. PCOS: metabolic impact and long-term management.
Carmina E
Minerva Ginecol; 2012 Dec; 64(6):501-5. PubMed ID: 23232534
[TBL] [Abstract][Full Text] [Related]
12. Cigarette Smoking and Atherosclerotic Cardiovascular Disease.
Ishida M; Sakai C; Kobayashi Y; Ishida T
J Atheroscler Thromb; 2024 Mar; 31(3):189-200. PubMed ID: 38220184
[TBL] [Abstract][Full Text] [Related]
13. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-155 Attenuates Detrimental Vascular Effects of Tobacco Cigarette Smoking.
Frati G; Forte M; di Nonno F; Bordin A; Chimenti I; Picchio V; Cavarretta E; Stanzione R; Bianchi F; Carnevale R; Nocella C; Schiavon S; Vecchio D; Marchitti S; De Falco E; Rubattu S; Paneni F; Biondi-Zoccai G; Versaci F; Volpe M; Pagano F; Sciarretta S
J Am Heart Assoc; 2020 Dec; 9(24):e017000. PubMed ID: 33317369
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy.
Rodella LF; Favero G; Rossini C; Foglio E; Reiter RJ; Rezzani R
Life Sci; 2010 Oct; 87(17-18):558-64. PubMed ID: 20854829
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
17. Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome.
Duică F; Dănilă CA; Boboc AE; Antoniadis P; Condrat CE; Onciul S; Suciu N; Creţoiu SM; Varlas VN; Creţoiu D
Front Endocrinol (Lausanne); 2021; 12():614679. PubMed ID: 33679617
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5α-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Milutinović DV; Nikolić M; Veličković N; Djordjevic A; Bursać B; Nestorov J; Teofilović A; Antić IB; Macut JB; Zidane AS; Matić G; Macut D
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):522-529. PubMed ID: 28407665
[TBL] [Abstract][Full Text] [Related]
19. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
Baldani DP; Skrgatic L; Ougouag R; Kasum M
Gynecol Endocrinol; 2018 Feb; 34(2):87-91. PubMed ID: 28944709
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
